AAPG vs CDT โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
AAPG Captures Institutional Edge (3โ1 Pillars ยท 6โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Ascentage Pharma Group International American Depository Shares (AAPG) driven by superior Valuation, Momentum & Technical, Options & Structure while CDT counters with relative strength in Growth & Margin. Fundamentally, AAPG trades at 8.4x Forward P/E with -219.5% operating margin (+29.3% YoY revenue) versus CDT at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, AAPG sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against CDT sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | AAPG | CDT | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $1.2B | $507,528 | Larger Scale | AAPG |
| Trailing P/E Ratio Valuation | 8.4x | N/M | Lower Multiple | AAPG |
| Forward P/E Ratio Valuation | 8.4x | N/M | Lower Multiple | AAPG |
| Revenue Growth (YoY) Growth | +29.3% | +0.0% | Higher Growth | AAPG |
| Operating Margin (TTM) Profitability | -219.5% | 0.0% | Higher Margin | CDT |
| Net Profit Margin Profitability | -228.5% | 0.0% | Higher Margin | CDT |
| Return on Equity (ROE) Capital Efficiency | -236.6% | -69.7% | Higher ROE | CDT |
| 52-Week Range Position Momentum | 0% ($12โ$34) | 2% ($0โ$11) | Stronger Trend | CDT |
| Beta / 30D Volatility Risk Regime | 1.36ฮฒ ยท 64% Vol | -17.75ฮฒ ยท 10175% Vol | Lower Realized Risk | AAPG |
| Unified Institutional Score Composite Signal | 37.1 / 100 (SELL) | 31.6 / 100 (SELL) | Higher Composite | AAPG |